TransEnterix to Participate in Two Upcoming Virtual Healthcare Conferences
January 04 2021 - 6:55AM
Business Wire
TransEnterix, Inc. (NYSE American: TRXC) announced today that
Anthony Fernando, President and Chief Executive Officer, and
Shameze Rampertab, Executive Vice President and Chief Financial
Officer, will present at two upcoming virtual investor
conferences:
- Presentation at the H.C. Wainwright BioConnect 2021 Conference
available for on-demand listening beginning Monday, January 11,
2021, at 6:00 am Eastern Time.
- Digital Surgery Panel presentation at the Westwicke/ICR
Conference 2021 on Thursday, January 14, 2021 at 10:00 am Eastern
Time. The panel will be moderated by Ryan Zimmerman, Managing
Director, Equity Research - Medical Technology at BTIG.
- Presentation at the Westwicke/ICR Conference 2021 on Thursday,
January 14, 2021 at 3:15 pm Eastern Time.
The on-demand H.C. Wainwright BioConnect 2021 conference
presentation and the live audio webcast of the ICR conference
presentations will be available online at the investor relations
page of the Company’s website at
http://ir.transenterix.com/events.cfm. Replays of the webcasts will
be archived on the website for approximately 90 days.
About TransEnterix
At TransEnterix, Inc., we are digitizing the interface between
the surgeon and the patient to improve minimally invasive surgery
(MIS) through a new category of care called Digital Laparoscopy.
Digitizing the interface enables the use of advanced capabilities
like augmented intelligence, connectivity and robotics in
laparoscopy, and allows us to address the current clinical,
cognitive and economic shortcomings in surgery. The system features
the first machine vision system for use in robotic surgery which is
powered by the new Intelligent Surgical Unit™ (ISU™) that enables
augmented intelligence in surgery. The Senhance Surgical System
brings the benefits of Digital Laparoscopy to patients around the
world while staying true to the principles of value-based
healthcare. Learn more about Digital Laparoscopy with the Senhance
Surgical System here: https://Senhance.com/. Now available for sale
in the US, the EU, Japan, and select other countries. For a
complete list of indications for use, please visit:
https://www.transenterix.com/indications-for-use/.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210104005097/en/
For TransEnterix, Inc. Investor Contact: Mark Klausner, +1
443-213-0501 invest@transenterix.com or Media Contact: Terri
Clevenger, +1 203-682-8297 terri.clevenger@icrinc.com
TransEnterix (AMEX:TRXC)
Historical Stock Chart
From Aug 2024 to Sep 2024
TransEnterix (AMEX:TRXC)
Historical Stock Chart
From Sep 2023 to Sep 2024